Showing results (181-190 of 276) with videos related to

Sort By:
Pageof 28
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 6, 2021
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)Günter Emons, Jae-Weon Kim, Karin Weide, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
JAMA Network Open|April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic AberrationsPhilip C Schouten, Sandra Schmidt, Kerstin Becker, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?Nicolò Bizzarri, Majdi Imterat, Robert Fruscio, et al.
Gynecologic Oncology|December 25, 2021
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialPhilipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata, et al.
Gynecologic Oncology|January 8, 2016
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 studyPhilipp Harter, Toby Johnson, Dominique Berton-Rigaud, et al.
Gynecologic Oncology|August 28, 2024
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS studyLenka Fricová, Stefan Kommoss, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)Melisa Guelhan Inci, Ebru Ilter, Eva Roser, et al.
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.
Pageof 28